Intrafusal effects of botulinum toxin in post-stroke upper limb spasticity

Eur J Neurol. 2008 Apr;15(4):367-70. doi: 10.1111/j.1468-1331.2008.02076.x. Epub 2008 Feb 11.

Abstract

A previous study in subjects with focal dystonia suggested that the greater and longer-lasting effect induced by botulinum toxin type A (BoNT-A) on the tonic vibration reflex (TVR) than on the maximal M-wave (M-max) might be the physiological marker of the toxin's action at the level of intrafusal muscle fibres. With this approach, we investigated the possible effect of BoNT-A on fusimotor synapses in eight patients with post-stroke spasticity (four with no residual motor capacity before treatment and four with partially spared muscle strength and residual motor capacity). TVR and M-max were recorded from the wrist and finger flexor muscles before treatment and at 1, 4 and 7 months afterwards. The TVR reduction was greater than the M-max reduction and remained fairly constant over time only in the subjects with a residual motor capacity before the treatment. This pilot study suggests that some degree of strength and active movement is necessary for the action of BoNT-A on intrafusal fibres.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Analysis of Variance
  • Botulinum Toxins, Type A / administration & dosage*
  • Electromyography / methods
  • Female
  • Humans
  • Injections, Intramuscular / methods
  • Male
  • Middle Aged
  • Muscle Contraction / drug effects
  • Muscle Spasticity / drug therapy*
  • Muscle Spasticity / etiology
  • Muscle Spasticity / pathology*
  • Neuromuscular Agents / administration & dosage*
  • Reflex, Stretch / drug effects
  • Stroke / complications
  • Upper Extremity*

Substances

  • Neuromuscular Agents
  • Botulinum Toxins, Type A